BHCM
LNAI

Boulder Hill Capital Management’s Lunai Bioworks LNAI Stock Holding History

Boulder Hill Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-133
Closed -$20K – 186
2022
Q2 		$20K Buy
+133
New +$60.8K 0.02% 92
2022
Q1 		– Sell
-224
Closed -$130K – 220
2021
Q4 		$130K Buy
+224
New +$163K 0.13% 147

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boulder Hill Capital Management's LNAI Position: Q3 2022 in Review

Boulder Hill Capital Management sold out of Lunai Bioworks (LNAI) in Q3 2022, closing a stake of 133 shares — an estimated $20K sold.

Boulder Hill Capital Management first reported a position in LNAI in Q4 2021 and held it in 2 quarters. The position peaked at $130K in Q4 2021. 42 funds tracked by Wall St. Rank hold LNAI as of Q3 2022.

  • Boulder Hill Capital Management reported no remaining Lunai Bioworks position as of Q3 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 133 Lunai Bioworks shares in Q3 2022, an estimated $20K.
  • Boulder Hill Capital Management first reported a position in Lunai Bioworks in Q4 2021 and held it in 2 quarters.
  • Boulder Hill Capital Management's Lunai Bioworks position peaked at $130K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2022.

Based on Boulder Hill Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.